Off late some customers are requesting clarity on the above safety communications warning issued by US FDA about usage of thermography for screening, detection or diagnosis. There are some important considerations showing why the Niramai solution is not the same as Thermography, and those differences are detailed below:
Thermalytix has regulatory clearance in India, Europe, UAE and Kenya at this time and usage in these countries does not fall under the purview of the above mentioned US FDA communication.
We recently obtained US FDA clearance for our SMILE-100 tool that has subset of features of Thermalytix. However, Thermalytix is not yet approved in USA.
NIRAMAI is the pioneer of a patented technology called Thermalytix© which is a novel fusion of Artificial Intelligence and Thermography for Breast Screening. NIRAMAI early stage breast cancer screening solution is a non-contact, non-invasive, portable, safe, automated solution that works for women of all ages. The novel AI and ML algorithms for the analysis of thermal images have resulted in Nine granted US patents and many more patent applications.
Thermography is visual analysis of thermal images. It has been in practise by many medical professionals around the world as an adjunct modality to detect early stage breast cancer screening. However, manual analysis of thermal images requires highly trained skilled professionals, and many times results in a number of false positives.
NIRAMAI’s Thermalytix solution addresses this issue using machine intelligence and provides an accurate, automated method of screening for early stage breast cancer and other breast abnormalities. NIRAMAI Thermalytix has much higher accuracy than Thermography.
Niramai solution is based on Thermography. Niramai thermal device which is placed 3 feet in front of the patient captures 5 thermal images of the region. Niramai software tool automatically analyses these images and sends the analysis report that is certified by a Senior Radiologist.
For more details, please watch this video https://www.youtube.com/watch?v=Eo2Z0a_9lyY
Ideal time period for a woman is from ovulation to the onset of menstruation.
Please click on the link “Register for Screening” and share your details or just drop a note on the contact form with your location and contact details. Our customer support will reach out to you for an appointment in the nearest centre.
Alternatively, you can find a center on Google Map with search keyword “Niramai Breast Clinic near me”. Many of our centers are listed there.
Niramai test is available in 150+ locations in India, Kenya, Philippines, Sweden, Bulgaria, Turkey and UAE.
There is no minimum age for thermographic screening. It doesn’t depend on the age, color, race and density of breast. Any girl post menstruation should be conscious of her breast health.
No. Thermography is a non-contact, non-invasive and radiation free modality, unlike mammography where 10 kg pressure is applied. Thermography just measures temperature, there is no harmful radiation exposure too.
Yes. NIRAMAI Thermalytix has received regulatory approval from India, Kenya, UAE, Philippines and all countries in Europe (CE Mark). SMILE-100 (with subset of features of Thermalytix) is regulatory cleared by US FDA.
All Thermal devices used along with Thermalytix software are also US FDA cleared and have European CE Mark.
If you are hospital or diagnostic centre interested in deploying this solution in your centre, please drop a note to email@example.com. We will arrange a free demonstration of the solution and discussion with Niramai BD team. Niramai test is now deployed in 150+reputed hospitals and diagnostic centers such as Apollo Clinics, HCG, Narayana Health and more.
If you are a corporate interested in your employee wellness or an NGO interested in conducting screening camps for women, Niramai solution is available on monthly or daily-rental basis too. Please drop us a note on firstname.lastname@example.org .
For deeper collaboration with Niramai, please write to email@example.com
It depends on how close you are with the relative. If the relative is a first degree relative (Parent, Sibling or Child) you have a more risk of cancer and is recommended to go for frequent screening. If the relative is a second degree relative, the risk is less compared to former.
Early detection is very important to have a good cure. We recommend Thermalytix scan once a year for all females above 25 years. Since Thermalytix give breast health scores, if your score is all zero, you can repeat it once in 2 years, instead.
Patients suffering from fever can postpone their screening to a future date, just to avoide inconvenience to them. Alcoholic beverages should not be consumed for twelve hours prior to the test. Hot tea or coffee should be avoided for at least one full hour before examination. Aspirins, pain medications, vasodilators, constrictors should be avoided for 24 hours prior to test.
While the global guidance advices women above 45 years to take a breast cancer screening test every year, statistics from World Health Organization (WHO) shows that the incidence rates for women below 40 years is also increasing. About 28% of breast cancer deaths are under 45 year. This would worsen in future due to stress, changes in lifestyle and increase in pollution. So, we recommend all women above 25 years to undergo breast screening using radiation-free Thermalytix test at least once. Based on the scoring, we give personalized recommendation on when you need to repeat the test.